The Searle Company Ltd News
_20260429102856549_d248f0.jpeg%3Fwidth%3D950%26height%3D450%26format%3DWebp&w=3840&q=75)
MettisPositive coverageSearle profit rises 31% to Rs1bn in 1QFY27The Searle’s quarterly profit rose 30.77% to Rs1.20 billion.- MettisPositive coverageVIS reaffirms The Searle Company's long-term rating at 'AA-'VIS reaffirmed Searle's entity ratings at 'AA-/A1' with a 'Stable' outlook.
MettisPositive coverageSearle swings to Rs536m profit, declares Rs1/share dividendSearle posted a consolidated net profit of Rs535.74m for the year ended June 30, 2026.
MettisPositive coverageSEARL charts biotech-led future with global expansion plansSEARL management projects global pharma growth of ~5-8% a year, reaching $2.6tr by 2030.
ProfitPositive coverageSearle subsidiary signs MoUs to manufacture biological products for Martin Dow Marker, AtcoThe Martin Dow Marker tie-up is a memorandum of understanding on biological products.
ProfitNeutral coverageSearle Company plans transfer of biologics portfolio to Nextar, proposes ₨4 billion investmentSearle plans to move its biologics portfolio to indirect subsidiary Nextar Pharma.
BRNeutral coveragePakistani pharma Searle to transfer biologic portfolio to NextarBoard proposed an investment of up to Rs4 billion in Nextar Pharma (Private) Limited..png%3Fwidth%3D950%26height%3D450%26format%3DWebp&w=3840&q=75)
MettisNeutral coverageSearle to transfer biologic portfolio to NextarSearle's board approved moving its biologics portfolio to indirect subsidiary Nextar Pharma.
More market stories are on the PSX news page.
Community
SEARL discussion
8 posts about The Searle Company Ltd
Based on 1 comment that took a side in the last 7 days.
Open the discussion to read them.
Comments are the personal opinions of community members, not investment advice. Do your own research before you invest. Company updates from @InvestifyUpdates are automatic summaries of PSX announcements, so check the original announcement.
Join the discussionAbout SEARL news
The Searle Company Ltd (SEARL) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. Read the latest Investify News Desk reports and publisher stories linked to this company, each tagged with how the story reads for the stock. A headline is context, not a signal: check it against the company's own announcements.
SEARL news questions
Where can I read the latest news about The Searle Company Ltd (SEARL)?
This page lists the most recent stories linked to The Searle Company Ltd: reports by the Investify News Desk and summaries of stories from Pakistani publishers. Each links to its own page with the sources it is based on.
What does the sentiment label on a SEARL story mean?
It describes how the story reads for SEARL (positive, negative or neutral), assigned automatically from the text. It is not a rating, a forecast of the share price or a recommendation to trade.
Where do I confirm a SEARL headline?
Company news is confirmed by the company's own filings. Open the announcements for SEARL to read the notice itself, with its dates and terms.
SEARL company announcementsExplore other Pharmaceuticals shares
Investor tools
Run the numbers on SEARL
PSX guides
Read the news with the filings
How to check a headline against the company's own announcements and results before you act on it.
How to Research PSX Companies Before Buying Shares
A practical PSX company research checklist for beginners: read stock pages, fundamentals, charts, technicals, announcements, annual reports and market news before buying.
Read guide
PSX Company Announcements Explained: Results, Dividends, Board Meetings, Book Closure, Rights and Bonus Issues
Learn what PSX company announcements mean - results, dividends, book closure, bonus shares and rights issues - and how to read them in Investify.
Read guide
Common Mistakes Beginners Make in the Pakistan Stock Exchange
A practical guide to common PSX beginner mistakes, including chasing tips, overtrading, ignoring risk, skipping research and not tracking portfolio decisions.
Read guideData source: Market data is provided under a Pakistan Stock Exchange data license held by Recube Technologies (investify.pk), listed on the official PSX services page. Quotes, charts and derived figures are for information only and may be delayed, adjusted or revised by the exchange.
Not financial advice: Investify is not a brokerage and does not provide investment, trading or financial advice. Nothing on this page is a recommendation to buy or sell any security. Do your own research or consult a licensed advisor before making investment decisions. Read our data & editorial policy.
